Recruiting
Phase 2

Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies

Sponsor:

Georgetown University

Code:

NCT04002674

Conditions

Dementia With Lewy Bodies

Eligibility Criteria

Sex: All

Age: 25 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo oral capsule

Nilotinib Oral Capsule

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information